As interventions that affect the course of Alzheimer's disease (AD) become available, it will be more important to diagnose AD at its earliest stages. The goal of this project is to identify, using functional magnetic resonance imaging (fMRI), changes in cerebral physiology occurring in the pre-symptomatic phase of AD by studying persons with Presenilin-1 (PS1) mutations giving rise to autosomal dominant AD. As a career development award another goal is to train the principal investigator in the design, implementation, and interpretation of fMRI experiments.
The specific aims are: 1) To establish if there are changes in the pattern of cerebral activity associated with episodic memory detectable on fMRI prior to overt decline in cognitive function in persons destined to develop PSI-related AD, 2) To establish if there are changes on fMRI in the pattern of cerebral activity associated with a test of executive function in this population, and 3) To determine if these changes occur as early as young adulthood. We will compare blood oxygen level dependent fMRI measures between 24 PS1 mutation carriers and 24 non-carriers during performance of two memory tasks and a test of executive function. The subjects will be pre-symptomatic at-risk members of 6 Mexican families with PS1 mutations determinant for early-onset AD. Subjects will undergo genetic testing, 3 hours of cognitive testing, and fMRI scanning over two days. The memory tasks will consist of: 1) a auditory paired-associate word memory test, and a 2) a semantic encoding task followed by a recognition test. A test of executive function will also be given in which subjects repress a natural button-press response on some trials. Analyses will include both within-subjects comparisons of regions of interest and group-averaged statistical parametric mapping comparisons. FMRI measures will also be compared between PS1 mutation carriers and non-carriers in young and older age groups. The lead researcher has fellowship training in dementia and seeks to become independent in cognitive research, including functional neuroimaging modalities such as fMRI. This award will allow time for the research and necessary classes in functional imaging, statistics, and cognitive science. UCI, with its strong dementia research program, growing MRI capabilities and opportunity to collaborate at the nearby UCLA Brain Imaging Center, is an excellent environment for this endeavor.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08AG022228-04
Application #
6927144
Study Section
Special Emphasis Panel (ZAG1-ZIJ-1 (J3))
Program Officer
Phelps, Creighton H
Project Start
2003-08-01
Project End
2007-07-31
Budget Start
2005-09-01
Budget End
2007-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$160,561
Indirect Cost
Name
University of California Los Angeles
Department
Neurology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Joe, Elizabeth; Medina, Luis D; Ringman, John M et al. (2018) 1H MRS spectroscopy in preclinical autosomal dominant Alzheimer disease. Brain Imaging Behav :
Petok, Jessica R; Myers, Catherine E; Pa, Judy et al. (2018) Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers. Neurobiol Aging 65:149-157
Tseng, Chi-hong; Elashoff, Robert; Li, Ning et al. (2016) Longitudinal data analysis with non-ignorable missing data. Stat Methods Med Res 25:205-20
Soosman, Steffan K; Joseph-Mathurin, Nelly; Braskie, Meredith N et al. (2016) Widespread white matter and conduction defects in PSEN1-related spastic paraparesis. Neurobiol Aging 47:201-209
Ting, Simon Kang Seng; Benzinger, Tammie; Kepe, Vladimir et al. (2014) A novel PSEN1 mutation (I238M) associated with early-onset Alzheimer's disease in an African-American woman. J Alzheimers Dis 40:271-5
Hooper, Megan; Grill, Joshua D; Rodriguez-Agudelo, Yaneth et al. (2013) The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemp Clin Trials 36:256-62
O'Neill, Joseph; Gorbis, Eda; Feusner, Jamie D et al. (2013) Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder. J Psychiatr Res 47:494-504
Braskie, Meredith N; Medina, Luis D; Rodriguez-Agudelo, Yaneth et al. (2013) Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease. Hum Brain Mapp 34:3308-19
Ringman, John M; Coppola, Giovanni (2013) New genes and new insights from old genes: update on Alzheimer disease. Continuum (Minneap Minn) 19:358-71
Lee, Grace J; Lu, Po H; Medina, Luis D et al. (2013) Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations. J Neurol Neurosurg Psychiatry 84:154-62

Showing the most recent 10 out of 37 publications